Literature DB >> 3667124

Immune studies by the use of Multitest-Merieux in patients with kidney tumours.

I Romics1, D Répássy, G Kulcsár, P Brühl.   

Abstract

Responsiveness to recall antigens was studied by the use of Multitest-Merieux in 20 cases of kidney tumour with and without deposits. The patients of either group, compared with the controls, had depressed scores of immunoreactivity. After surgical removal of the tumour-bearing kidney, immunoreactivity increased, regardless of the presence or absence of deposits. The number of reacting antigens also increased in every case. Lymphocyte transformation in vitro was also depressed, in comparison with the controls before surgery, but after the intervention the transformed blast cells increased in number. Multitest was found suitable for studies of delayed-type sensitivity.

Entities:  

Mesh:

Year:  1987        PMID: 3667124     DOI: 10.1007/bf02550460

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Studies on the immune status of patients with renal adenocarcinoma.

Authors:  S Brosman; M Hausman; S J Shacks
Journal:  J Urol       Date:  1975-09       Impact factor: 7.450

2.  Demonstration of cell-mediated immunity to human neoplasms of various histological types.

Authors:  I Hellström; K E Hellström; H O Sjögren; G A Warner
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

3.  Cell mediated cytotoxicity against human transitional cell carcinomas of the genitourinary tract.

Authors:  T R Hakala; P H Lange; A Castro; A Elliott; E E Fraley
Journal:  Cancer       Date:  1974-12       Impact factor: 6.860

4.  Defective cell-mediated immunity in carcinoma of the prostate.

Authors:  J W Thomas; G Jerkins; C Cox; P Lieberman
Journal:  Invest Urol       Date:  1976-07

5.  Immune response in bladder cancer patients.

Authors:  S Brosman; M Elhilali; C Vescera; J Fahey
Journal:  J Urol       Date:  1979-02       Impact factor: 7.450

6.  Immune evaluation with skin tests in prostatic carcinoma.

Authors:  A T Lachand; C Martin-Mondières
Journal:  Eur Urol       Date:  1979       Impact factor: 20.096

7.  Study of nonspecific lymphocyte transformation in urologic cancer patients.

Authors:  I Romics; J Horváth
Journal:  Int Urol Nephrol       Date:  1978       Impact factor: 2.370

8.  Effect of levamisol on cellular and humoral immune reactivity and on recurrences in patients with bladder papilloma.

Authors:  I Romics; J Horváth; J Fehér; A Csontai
Journal:  Int Urol Nephrol       Date:  1985       Impact factor: 2.370

9.  Concanavalin A-inducible suppressor cells in regional lymph nodes of cancer patients.

Authors:  W J Catalona; T L Ratliff; R E McCool
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

10.  Transferrin, C3 complement, haptoglobin, plasminogen and alpha 2-microglobulin in patients with urogenital tumors.

Authors:  U Dunzendorfer; K Jung; G Ohlenschläger
Journal:  Eur Urol       Date:  1980       Impact factor: 20.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.